عرض الرسائل ذات التصنيف Pioglitazoneعرض الكل
Consider Actos for NASH patients Pioglitazone

Consider Actos for NASH patients

Mahitab Hany, BS Pharm, PGDipClinPharm, PGDipClinNutrition يناير 30, 2022

As a hospital pharmacist, you will see more nonalcoholic fatty liver disease (NAFLD) . According to studies, up to 100 million Americans have this buildup of fat in the liver. It often goes hand in hand with obesity , dyslipidemia , insulin resistance , and diabetes . About 20% of patients with NAFLD have nonalcoholic steatohepatitis (NASH) , the mo…

قراءة المزيد
Overview of nonalcoholic fatty liver disease (NAFLD) Vitamin-E

Overview of nonalcoholic fatty liver disease (NAFLD)

Abdelwahab Ward, BS Pharm, PharmD ديسمبر 01, 2020

N onalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world. Severity ranges from mild disease with steatosis (buildup of fat in the liver) to more severe disease with inflammation and hepatocyte (liver cell) injury known as nonalcoholic steatohepatitis (NASH). NASH is projected to be the leading liver transplant indication by the …

قراءة المزيد